Cutaneous leishmaniasis: Schedules for intralesional treatment with sodium stibogluconate

International Journal of Dermatology

Volumn 35, Issue 8, 1996, Pages 594-597

  Tallab, Talal M ^a   Bahamdam, Khalid A ^b   Mirdad, Soleman ^b   Johargi, Hanan ^b   Mourad, Mohamed Mazen ^b   Ibrahim, Karam ^b   El Sherbini, Abdul Hameed ^b   Karkashan, Eman ^b   Khare, Ashok Kumar ^b   Jamal, Awatif ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STIBOGLUCONATE SODIUM;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; SKIN LEISHMANIASIS;

EID: 9344238192     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb03669.x     Document Type: Article

References (33)

1. Albanese G, Giorgette P, Santagostino L, Grippa D. Cutaneous leishmaniasis: treatment with itraconazole. Arch Dermatol 1989; 125:1540-1542.
2. Al-Gindan Y, Abdulaziz O, Kubba R. Cutaneous leishmaniasis in Al-Hassa, Saudi Arabia. Int J Dermatol 1984; 23:194-197.
3. Peters W, Al-Zahrani MA. The leishmaniases - a public health problem in Saudi Arabia. Saudi Med J 1987; 8: 333-343.
4. Al-Zahrani MA, Peters W, Evans A, et al. Leishmania infecting man and wild animals in Saudi Arabia. 6. Cutaneous leishmaniasis of man in the South-West. Trans Soc Trop Med Hyg 1989; 83:621-628.
5. Dye C, Killick-Kendrick R, Ben Ismail R, Al-Gindany. Zoonotic cutaneous leishmaniasis in Saudi Arabia: results of a preliminary epidemiological survey in Al-Hasa Oasis. Trans R Soc Med 1989; 83; 493-498.
6. Al-Shammari S, Khoja T, Fehr A. Cutaneous leishmaniasis in Riyadh region: four-year study of the epidemiological and clinical features. Int J Dermatol 1992; 31: 565-567.
7. Buttiker W, Al-Ayed JH, Al-Wabel AH, et al. Medical and applied zoology in Saudi Arabia. A preliminary study on leishmaniasis in two areas of Asir region. Fauna Saudi Arabia 1982; 4:509-519.
8. Ophir J, Krakowiski A, Benner S. Miconazole treatment for cutaneous leishmaniasis. J Infect Dis 1983; 148:1168.
9. Akuffo H, Dietz M, Teklemariam S, et al. The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica. Trans R Soc Trop Med Hyg 1990; 84:532-534.
10. Pareek SS. Combination therapy of sodium stibogluconate and rifampicin in cutaneous leishmaniasis. Int J Dermatol 1984; 23:70-71.
11. El-Safi SH, Marphy AG, Bryceson DM, Neal RA. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment. Trans R Soc Med Hyg 1990; 84:690-691.
12. Weinrauch L, Livshin R, Even-Paz Z, El-On J. Efficacy of ketoconazole in cutaneous leishmaniasis. Arch Dermatol Res 1983; 275:353-354.
13. Dogra J. A double-blind study on the efficacy of oral dapsone in cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1991; 85:212-213.
14. Cohen HA, Wahaba A. Treatment of leishmaniasis recidivens with intralesional injections of emetine hydrochloride: a case report. Acta Derm Venereol (Stockh) 1977; 59:549-552.
15. Leibovic V, Aram H. Cryotherapy in acute cutaneous leishmaniasis. Int J Dermatol 1986; 27:473-475.
16. Harms G, Zwingenberger K, Chehade AK, et al. Effects of intradermal gamma-interferon in cutaneous leishmaniasis. Lancet 1989; i:1287-1292.
17. Saenz RE, Paz HM, Johnson CM, et al. Treatment of American cutaneous leishmaniasis with orally administered allopurinol riboside. J Infect Dis 1989; 160:153-158.
18. Kandil E. Treatment of cutaneous leishmaniasis with trimethoprim-sulfamethoxazole. JAMA 1973; 223: 1378-1379.
19. Peters W, Lainson R, Shaw JJ, et al. Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis. Lancet 1981; i:1122-1124.
20. Ganor S. Treatment of leishmaniasis recidivans with local injections of amphotericin B. Dermatol Int 1967; 6:141-143.
21. Dostrowski A, Sagher F. Treatment of cutaneous leishmaniasis (oriental sore) by grenz rays. Arch Dermatol 1942; 45:865-875.
22. Ghos S. Evaluation of sodium stibogluconate in treatment of cutaneous leishmaniasis. Curr Med Res Opin 1978; 6:280-283.
23. Sharique KE, Al-Talib KK, Chu AC. Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. Br J Dermatol 1988; 119:53-57.
24. Faris RM, Zorallah JS, Khoja TA, Al-Yamani J. Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. Int J Dermatol 1993; 32:610-612.
25. Harms G, Chehad AK, Doub M, et al. A randomized trial comparing a pentavalent antimony and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1991; 85:214-216.
26. Kellum RE. Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (pentostam). J Am Acad Dermatol 1986; 15:620-622.
27. El-Darouti MA, Al Rubaie SM. Cutaneous leishmaniasis. Treatment with combined cyrotherapy and intralesional stibogluconate injection. Int J Dermatol 1990; 29:56-59.
28. El Safi SH, Peter SW, El-Toam B, et al. Studies on the leishmaniasis in the Sudan. 2. Clinical and parasitological studies on cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1991; 85:457-464.
29. Herwaldt BL, Berman JD. Recommendation for treating leishmaniasis with sodium stibogluconate (pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992; 46:296-306.
30. Ballow WR, McClain JB, Gordon DM, et al. Safety and efficacy of high dose sodium stibogluconate for therapy of American cutaneous leishmaniasis. Lancet 1987; ii: 13-16.
31. Berman JD, Hanson BD. Biochemical mechanism of antileishmanial activity of sodium stibogluconate. Anti Microb Agent Chemother 1985; 27:16-20.
32. Berman JD. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy and future strategies. Rev Infect Dis 1988; 10:560-586.
33. Grogl M, Odoula AM, Corder LD, Kyle DE. Leishmania spp.: Development of pentostam-resistant clones in vitro by discontinuous dry exposure. Exp Parasitol 1989; 69:78-90.